Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD

INTRODUCTION: Patients with COPD often show increased systemic inflammation which is associated with lower functional status, greater exacerbation risk, and worse clinical outcomes. Syndecans (SDCs), a family of transmembrane heparan sulfate proteoglycans (HSPGs), have been found to involve in infla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Li, Diandian, Wu, Yanqiu, Guo, Shujin, Qin, Jiangyue, Feng, Mei, An, Yunfei, Zhang, Junlong, Li, Yanping, Xiong, Shuguang, Zhou, Hui, Zeng, Qianglin, Chen, Lei, Wen, Fuqiang
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718058/
https://ncbi.nlm.nih.gov/pubmed/31695352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S207855
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars